Immunization of ovarian cancer patients
β
Paul J. Sabbatini; Valery Kudryashov; Govindaswami Ragupathi; Samuel J. Danishef
π
Article
π
2000
π
John Wiley and Sons
π
French
β 138 KB
π 2 views
As the initial step in developing carbohydrate-based vaccines for the treatment of ovarian cancer patients in an adjuvant setting, 25 patients were immunized with a Lewis y pentasaccharide (Le y )-keyhole limpet hemocyanin (KLH)conjugate vaccine together with the immunological adjuvant QS-21. Four d